Samsung Bioepis CH GmbH
Samsung Bioepis CH GmbH is a Biotech company based in Luzern (Lucerne) recorded by Swissmedic as the authorisation holder for 11 human medicines. That places it 142 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Biotechnologika.
Key facts
| Sector | Biotech |
|---|---|
| City | Luzern |
| Canton | Lucerne |
| Authorisation holder | Yes |
| Medicines | 11 |
| Founded | Not available |
| Employees | 1-10 |
| Parent group | Samsung Bioepis Co., Ltd. |
| Activity | Not available |
| Website | samsungbioepis.com |
Medicines authorised in Switzerland
Samsung Bioepis CH GmbH is recorded by Swissmedic as the authorisation holder for 11 human medicines. The table shows 11 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
11 of 11 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Benepali 50 mg | 66323 | B | L04AB01 | 2018-09-10 |
| Benepali 50 mg | 66325 | B | L04AB01 | 2018-09-10 |
| Byooviz 10 mg / mL | 68690 | B | S01LA04 | 2022-07-13 |
| Byooviz 10 mg / ml | 70708 | B | S01LA04 | 2026-05-12 |
| Flixabi 100 mg | 70087 | A | L04AB02 | 2025-11-06 |
| Imraldi 40 mg/0.8 ml | 67427 | B | L04AB04 | 2020-04-03 |
| Imraldi 40 mg/0.8 ml | 67582 | B | L04AB04 | 2020-04-03 |
| Obodence | 69873 | B | M05BX04 | 2025-03-21 |
| Pyzchiva 130 mg | 69985 | B | L04AC05 | 2025-03-21 |
| Pyzchiva 45 mg/0.5 mL | 69986 | B | L04AC05 | 2025-03-21 |
| Xbryk 120 mg/1.7 ml | 69874 | A | M05BX04 | 2025-03-21 |
Frequently asked questions
How many medicines does Samsung Bioepis CH GmbH have authorised in Switzerland?
Samsung Bioepis CH GmbH is recorded by Swissmedic as the authorisation holder for 11 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Samsung Bioepis CH GmbH based?
The Swiss location recorded for Samsung Bioepis CH GmbH is Luzern, Lucerne.
Is Samsung Bioepis CH GmbH a Swissmedic authorisation holder?
Yes. Samsung Bioepis CH GmbH appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.